-
Mashup Score: 6EFSD and Lilly European Diabetes Research Programme | EFSD - 8 month(s) ago
The European Foundation for the Study of Diabetes (EFSD) was created by the European Association for the Study of Diabetes (EASD) to provide funding initiatives in all areas of diabetes research. The aims of EFSD are to encourage and support research in the field of diabetes, to rapidly diffuse acquired knowledge and to facilitate its application. Lilly has been a global leader in diabetes care since 1923, when Lilly introduced the world’s first commercial insulin. Today Lilly is building upon this
Categories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 14EFSD and Sanofi European Diabetes Research Programme on Autoimmunity in Type 1 Diabetes | EFSD - 9 month(s) ago
The European Foundation for the Study of Diabetes (EFSD) was created by the European Association for the Study of Diabetes e.V. (EASD) to provide funding initiatives in all areas of diabetes research. The aims of EFSD are to encourage and support research in the field of diabetes, to rapidly diffuse acquired knowledge and to facilitate its application. Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi is dedicated to delivering
Categories: General Medicine News, EndocrinologyTweet-
🚨New #research #funding programme on #autoimmunity in type 1 #diabetes available! #EFSD and @sanofi have established this programme to accelerate European research aimed at improving understanding of any aspect of autoimmunity in #t1d. https://t.co/cBWJP7yW6f https://t.co/WzVeDfZR2A
-
-
Mashup Score: 28EFSD Novo Nordisk Foundation Future Leaders Award Programme | EFSD - 10 month(s) ago
The European Foundation for the Study of Diabetes (EFSD) was created by the European Association for the Study of Diabetes (EASD) to provide funding initiatives in all areas of diabetes research. The aims of EFSD are to encourage and support research in the field of diabetes, to rapidly diffuse acquired knowledge and to facilitate its application. The Novo Nordisk Foundation is an independent Danish foundation with corporate interests. The Foundation has two objectives: 1) to provide a stable basis for
Categories: General Medicine News, EndocrinologyTweet-
📢 The #EFSD and @novonordiskfond Future Leaders Award Programme now calls for applications! The programme aims to identify outstanding early-career clinical and basic scientists and support their #career in European #diabetes #research. ▶️https://t.co/PuPssTpZgs https://t.co/DA6jbtONoc
-
-
Mashup Score: 13EFSD Albert Renold Travel Fellowship Programme | EFSD - 10 month(s) ago
Albert Renold Travel Fellowships enable scientists and clinicians to travel and stay at other institutions in order to learn specific techniques or clinical skills required for the advancement of their diabetes research project and not available at their home institution. The home and/or the host institution must be based in Europe or a Europe-associated country (for detailed country list, please see here), both must be non-profit and each must be in a different country. Applicants must be employed at
Categories: General Medicine News, EndocrinologyTweet-
🚨The popular #EFSD Albert Renold Travel #Fellowship Programme is available again! It enables scientists/clinicians to learn specific techniques or clinical skills at other institutions for the advancement of their #diabetes #research project 👉https://t.co/Uxc9eDHh7d https://t.co/jLdJf2uaWL
-
-
Mashup Score: 5EFSD/Boehringer Ingelheim European Research Programme on "Multi-System Challenges in Diabetes" | EFSD - 10 month(s) ago
EFSD/Boehringer Ingelheim European Research Programme on “Multi-System Challenges in Diabetes ” The European Foundation for the Study of Diabetes (EFSD) was created by the European Association for the Study of Diabetes (EASD) to provide multiple funding initiatives in all areas of diabetes research. The aims of EFSD are to encourage and support research in the field of diabetes, to rapidly diffuse acquired knowledge and to facilitate its application. Boehringer Ingelheim, is a leading research-driven
Categories: General Medicine News, EndocrinologyTweet-
🚨New #research #funding programme on multi-system challenges in #diabetes available! #EFSD & @Boehringer are encouraging innovative projects aimed at advancing current knowledge in inter-organ crosstalk and pathophysiology in diabetes, #obesity and #CVD https://t.co/yQiyZSowAD https://t.co/PiPyHaS6Kp
-
-
Mashup Score: 12EFSD and Sanofi European Diabetes Research Programme on Autoimmunity in Type 1 Diabetes | EFSD - 11 month(s) ago
The European Foundation for the Study of Diabetes (EFSD) was created by the European Association for the Study of Diabetes e.V. (EASD) to provide funding initiatives in all areas of diabetes research. The aims of EFSD are to encourage and support research in the field of diabetes, to rapidly diffuse acquired knowledge and to facilitate its application. Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi is dedicated to delivering
Categories: General Medicine News, EndocrinologyTweet-
🚨New #research #funding programme on #autoimmunity in type 1 #diabetes available! #EFSD and @sanofi have established this programme to accelerate European research aimed at improving understanding of any aspect of autoimmunity in #t1d. https://t.co/cBWJP7yW6f https://t.co/WzVeDfZR2A
-
-
Mashup Score: 30
The European Foundation for the Study of Diabetes (EFSD) was created by the European Association for the Study of Diabetes (EASD) to provide funding initiatives in all areas of diabetes research. The aims of EFSD are to encourage and support research in the field of diabetes, to rapidly diffuse acquired knowledge and to facilitate its application. Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic
Categories: General Medicine News, EndocrinologyTweet-
📢The #EFSD and @novonordisk programme for #funding diabetes research in #Europe is now open for applications! The programme offers funding for all fields of basic and clinical #diabetes #research. Application deadline: 1 February 2024 👉https://t.co/D3f3Pf6uie https://t.co/knxz6tioCC
-
-
Mashup Score: 23
The European Foundation for the Study of Diabetes (EFSD) was created by the European Association for the Study of Diabetes (EASD) to provide funding initiatives in all areas of diabetes research. The aims of EFSD are to encourage and support research in the field of diabetes, to rapidly diffuse acquired knowledge and to facilitate its application. The Novo Nordisk Foundation is an independent Danish foundation with corporate interests. The Foundation has two objectives: 1) to provide a stable basis for
Categories: General Medicine News, EndocrinologyTweet-
📢 The #EFSD and @novonordiskfond Future Leaders Award Programme now calls for applications! The programme aims to identify outstanding early-career clinical and basic scientists and support their #career in European #diabetes #research. ▶️https://t.co/PuPssTpZgs https://t.co/DA6jbtONoc
-
-
Mashup Score: 30
The European Foundation for the Study of Diabetes (EFSD) was created by the European Association for the Study of Diabetes (EASD) to provide funding initiatives in all areas of diabetes research. The aims of EFSD are to encourage and support research in the field of diabetes, to rapidly diffuse acquired knowledge and to facilitate its application. Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic
Categories: General Medicine News, EndocrinologyTweet-
📢The #EFSD and @novonordisk programme for #funding diabetes research in #Europe is now open for applications! The programme offers funding for all fields of basic and clinical #diabetes #research. Application deadline: 1 February 2024 👉https://t.co/D3f3Pf6uie https://t.co/knxz6tioCC
-
-
Mashup Score: 19
Euro 120,000 available for four Fellowships The EASD Rising Star Symposium and EFSD Rising Star Fellowship Programme aims to identify promising and innovative young researchers who are developing their research activities in Europe. Selected candidates will have the opportunity to present an overview of their past and ongoing research activities during a multidisciplinary research symposium at the EASD Annual Meeting. The chosen candidates will be invited by EASD to present a lecture (20 minute lecture +
Categories: General Medicine News, EndocrinologyTweet-
📢The @EASDnews Rising Star Symposium and #EFSD Rising Star Fellowship Programme is calling for applications! AIM: identify promising and innovative early career scientists and clinicians who are developing their #diabetes #research activities in Europe. https://t.co/3vO1fkossA https://t.co/Kv8oflpiX1
-
🚨#EFSD & @LillyDiabetesIn European Diabetes Research Programme welcomes applications! #Funding opportunity promoting #European #diabetes #research, basic or clinical, and to raise awareness and understanding of the magnitude and burden of the disease. https://t.co/dxIRjTb9N7 https://t.co/kqXp7lOiOM